BOSTON and ROLLE, Switzerland, July 25,
2023 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq:
SOPH), a cloud-native software company in the healthcare
space, today announced it will release its financial results
for the second quarter of fiscal 2023 before U.S. markets open on
Tuesday, August 8, 2023. On that day,
SOPHiA GENETICS will host a conference call to discuss its
financial results as well as business outlook beginning at
8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CEST.
The call will be webcast live on the SOPHiA GENETICS Investor
Relations website. Additionally, a replay will be available on the
website after its completion.
About SOPHiA GENETICS:
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native software company
in the healthcare space dedicated to establishing the practice of
data-driven medicine as the standard of care and for life sciences
research. It is the creator of the SOPHiA DDM™ Platform, a
cloud-native platform capable of analyzing data and generating
insights from complex multimodal data sets and different diagnostic
modalities. The SOPHiA DDM™ Platform and related solutions,
products and services are currently used by a broad network of
hospital, laboratory, and biopharma institutions globally. For more
information, visit SOPHiAGENETICS.COM, or connect
on Twitter, LinkedIn, Facebook, and Instagram. Where
others see data, we see answers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-the-second-quarter-of-fiscal-2023-on-august-8-2023-301884596.html
SOURCE SOPHiA GENETICS